Preparing for Your Targeted Treatment in the Clinic

• Patient recruitment

Big pharma tackles patient recruitment challenges, but we have a long way to go

Yesterday, Pfizer and Private Access, a search technology…

Read Article

• IRB

IRB Selection Tips from ClinPage

Suz Redfearn at ClinPage recently posted an excellent…

Read Article

• Drug development
• Phase I
• Phase II
• Speed to market
• Thought leaders

“Context of vulnerability” and its role in targeted drug development

Renowned cancer researcher Dr. Daniel Von Hoff and…

Read Article

• Contract research
• Drug development
• Phase I
• Thought leaders

The “Lost Opportunity” in Phase I Oncology Trials

Cancer drug developers traditionally use the phase I…

Read Article

• Biotech
• News
• Phase I trials
• Thought leaders

Dr. Dan Von Hoff honored at Governor’s Celebration

Our colleague Dan Von Hoff, M.D., a founder…

Read Article

• Drug development
• Genomics
• News
• Thought leaders

Personalized Genomics: The First Report of a Cancer Genome

As reported by the New York Times last…

Read Article

• News
• Thought leaders

Excellent cancer discussion on the Diane Rehm show

Yesterday morning’s Diane Rehm Show on NPR featured…

Read Article

• Internet

Discover clinical trial management, biotech and pharma resources on document-sharing web sites

We’ve recently begun using two web sites that…

Read Article

• Biotech
• Contract research
• Europe
• News

Medelis expands CRO services into Europe, appoints Dr. Deirdre Tessman to run the operation

We’re very pleased to announce that our colleague…

Read Article